Concepedia

Tony Siu

TS

Statistics

Publications

17

Citations

742

H-Index

15

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Columbia University

United States Military Academy

Kettering University

General Atomics (United States)

Tony Siu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacy, and drug discovery.

ORCID

Publications per year

2001–2023

17

Publications

17

Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING

Tony Siu, Michael D. Altman, Gretchen A. Baltus et al. · ACS Medicinal Chemistry Letters · 2018 · 172 citations · Full text

, , +14

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

Wonsuk Chang, Michael D. Altman, Charles A. Lesburg et al. · Journal of Medicinal Chemistry · 2022 · 137 citations · Full text

, , +17

Studies in the Total Synthesis of Heliquinomycinone: Proof of Concept and Assembly of a Fully Mature Spirocyclization Precursor

Donghui Qin, Rex X. Ren, Tony Siu et al. · Angewandte Chemie International Edition · 2001 · 60 citations

, , +16

Allosteric inhibitors of Akt1 and Akt2: Discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity

Yiwei Li, Jun Liang, Tony Siu et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 53 citations · Full text

, , +12

The Total Synthesis of Heliquinomycinone

Tony Siu, Donghui Qin, Samuel J. Danishefsky · Angewandte Chemie International Edition · 2001 · 52 citations

, , +15

1–5 of 17